Cleveland, Ohio
CNS clinical trials in Cleveland, OH
55 CNS studies are recruiting participants at sites in Cleveland as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Cleveland at a glance
- 55 studies are recruiting at a site in Cleveland.
- By phase: Phase 1 (1), Phase 1/2 (2), Phase 2 (5), Phase 2/3 (1), Phase 3 (12), Phase 4 (5), No phase (16), Observational (13). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (26), university, hospital or other (23), government (6).
- By research area: Parkinson's Disease (19), Multiple Sclerosis (14), Epilepsy (11), Depression (7), Migraine (2), Bipolar Disorder (1), Schizophrenia (1).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Cleveland
Basic details from each study's public record (the 30 most recently updated of 55). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Study site
- Cleveland Clinic
- Registry record
- NCT07002034 · updated
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- No phase
- Ages 22 to 70
- All sexes
- Sponsor
- Abbott Medical Devices
- Study site
- The Cleveland Clinic Foundation
- Registry record
- NCT06423430 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Cleveland, OH on ClinicalTrials.gov.
Schizophrenia studies recruiting in Cleveland
REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
- No phase
- Ages 18 to 50
- All sexes
- Sponsor
- Case Western Reserve University
- Study site
- Case Western Reserve University
- Registry record
- NCT07006935 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Cleveland, OH on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Cleveland
Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- University Hospitals Cleveland Medical Center
- Study site
- University Hospitals Cleveland Medical Center - Mood Disorders Program
- Registry record
- NCT03829787 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Cleveland, OH on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Cleveland
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Phase 3
- Ages 50 to 85
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Cleveland Clinic
- Registry record
- NCT07174310 · updated
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Phase 2
- Ages 30 to 80
- All sexes
- Sponsor
- Appello Pharmaceuticals, Inc.
- Study site
- Cleveland Clinic (Site #223)
- Registry record
- NCT07432958 · updated
Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Jay Alberts
- Study site
- The Cleveland Clinic
- Registry record
- NCT06442033 · updated
Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- The Cleveland Clinic
- Study site
- Cleveland Clinic
- Registry record
- NCT07442747 · updated
Decoding the Neural Mechanisms Underlying Postural Instability and Gait Dysfunction in Parkinson's Disease
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- The Cleveland Clinic
- Study site
- Cleveland Clinic
- Registry record
- NCT07748962 · updated
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Phase 2/3
- Ages 40 to 80
- All sexes
- Sponsor
- Biohaven Therapeutics Ltd.
- Registry record
- NCT06976268 · updated
BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease
- Phase 4
- Ages 40 and older
- All sexes
- Sponsor
- The Cleveland Clinic
- Study site
- Cleveland Clinic
- Registry record
- NCT07138560 · updated
Parkinson's Foundation PD GENEration Genetic Registry
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Parkinson's Foundation
- Study sites
- Case Western Reserve University · Cleveland Clinic
- Registry record
- NCT04994015 · updated
Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- The Cleveland Clinic
- Study site
- Cleveland Clinic
- Registry record
- NCT07110376 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Cleveland, OH on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Cleveland
Understanding and Enhancing Human Health and Movement
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- Louis Stokes VA Medical Center
- Study site
- Louis Stokes Cleveland VA Medical Center
- Registry record
- NCT07738978 · updated
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT06433752 · updated
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT06680037 · updated
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Phase 3
- Ages 40 to 70
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Cleveland Clinic Foundation
- Registry record
- NCT06846281 · updated
Care in Multiple Sclerosis (MS)
- Observational
- Ages 18 to 29
- All sexes
- Sponsor
- NYU Langone Health
- Study site
- Cleveland Clinic
- Registry record
- NCT07011914 · updated
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT05877963 · updated
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- Phase 3
- Ages 18 to 55
- All sexes
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Study site
- Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic
- Registry record
- NCT04047628 · updated
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Cleveland Clinic Ohio
- Registry record
- NCT07225504 · updated
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- UniQure Biopharma B.V.
- Study site
- Cleveland Clinic
- Registry record
- NCT06063850 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Cleveland, OH on ClinicalTrials.gov.
Epilepsy studies recruiting in Cleveland
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Registry record
- NCT07563881 · updated
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Cleveland Clinic Foundation
- Registry record
- NCT05667142 · updated
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Cleveland Clinic
- Registry record
- NCT05716100 · updated
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Phase 3
- Ages 2 and older
- All sexes
- Sponsor
- Epygenix
- Study site
- Cleveland Clinic
- Registry record
- NCT04462770 · updated
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
- Observational
- Ages 18 to 75
- All sexes
- Sponsor
- Epiminder America, Inc.
- Study site
- University Hospitals Cleveland Medical Center
- Registry record
- NCT07110454 · updated
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- Neurology Institute Epilepsy Center of Cleveland Clinic
- Registry record
- NCT06798896 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Cleveland, OH on ClinicalTrials.gov.
Migraine studies recruiting in Cleveland
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- University Hospitals Cleveland Medical Center
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- University Hospitals Cleveland Medical Center
- Registry record
- NCT04743141 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Cleveland, OH on ClinicalTrials.gov.
Ask about studies near Cleveland
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Ohio
All Ohio locations
175 studies recruiting across 37 cities.
Cincinnati
72 studies recruiting.
Columbus
54 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections